Background {#Sec1}
==========

Pancreaticoduodenectomy (PD) is one of the most complicated procedures in the field of gastroenterological surgery. As a result, the postoperative mortality and morbidity rates after PD remain high (2.8--3.5% and 40%, respectively) according to nationwide surveys performed in Japan \[[@CR1], [@CR2]\]. Furthermore, infectious complications after pancreatic surgery are common during the postoperative course, and can lead to fatal outcomes \[[@CR3]\]. High morbidity rates are associated with the need for further treatment and extended hospital stays. Thus, a precise method of predicting postoperative complications is urgently required to ensure patient safety following PD.

Recent studies have shown that computed tomography (CT)-assessed sarcopenia (radiographic sarcopenia), which is characterized by skeletal muscle depletion and is an objective predictor of frailty, is associated with poor outcomes in gastrointestinal and hepatopancreatobiliary malignancies \[[@CR4]\]. Previous studies have also shown that sarcopenia is associated with short-term outcomes, and especially with postoperative pancreatic fistula (POPF), in patients undergoing PD. \[[@CR5]--[@CR8]\] However, the influence of sarcopenia in terms of postoperative infectious complications has not been assessed in detail. We hypothesized that sarcopenia is associated with postoperative infections in patients undergoing PD.

With the above in mind, the aim of this retrospective study was to investigate postoperative outcomes following PD and to assess the influence of sarcopenia on short-term outcomes. In particular, we focused on the relationship between sarcopenia and infectious postoperative complications in patients following PD.

Methods {#Sec2}
=======

Patients {#Sec3}
--------

We retrospectively reviewed the medical records of 241 consecutive patients who underwent PD at the Okayama University Hospital between January 2007 and May 2013. This study was approved by the Ethics Committee of the Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences and Okayama University Hospital, and was conducted in accordance with the tenets of the Declaration of Helsinki. Due to the retrospective nature of the study, the need for informed consent was waived.

Clinical data {#Sec4}
-------------

For all enrolled patients, the following demographic and clinical data were evaluated as preoperative factors: sex, age, height, weight, body mass index (BMI), body surface area (BSA), American Society of Anesthesiologists (ASA) physical status, laboratory values (albumin level and total lymphocyte count), liver function according to the Child--Pugh score, comorbidities, etiology of disease, and preoperative biliary drainage. ASA physical status was preoperatively evaluated by an anesthesiologist. Preoperative biliary drainage included endoscopic biliary drainage and percutaneous transhepatic biliary drainage. Data regarding operative time, amount of blood loss, portal vein reconstruction, pancreatic texture (soft or hard) assessed by the surgeon intraoperatively, and main pancreatic duct diameter, were recorded as intraoperative factors.

Surgical procedures and perioperative management {#Sec5}
------------------------------------------------

The standard surgical procedure was subtotal stomach-preserving PD. The basic reconstruction of the digestive system was performed by means of a modification of the method described by Child \[[@CR9]\]. Pancreatojejunostomy was performed with a duct-to-mucosa anastomosis. Hepatojejunostomy was performed 10 cm distal to the pancreatojejunostomy. Gastrojejunostomy was performed by means of a two-layer anastomosis 50 cm distal to the hepatojejunostomy. A Braun anastomosis was also added. The details of these surgical techniques have been reported previously \[[@CR10], [@CR11]\]. In most cases, three drains were placed around the pancreatic and biliary anastomoses. All patients received prophylactic antibiotics every 3 h intraoperatively and for 3 d postoperatively.

Postoperative care was performed in a specialized surgical unit. Patients did not routinely receive somatostatin analogues and nutritional supplementation during the perioperative period. The drains were removed after postoperative day 5 if the drainage fluid was clear and no bacterial contamination was detected.

Image analysis and definition of sarcopenia {#Sec6}
-------------------------------------------

Diagnostic CT images taken within 3 months prior to surgery were chosen and evaluated using a CT image analysis system (Synapse Vincent; Fujifilm Medical, Tokyo, Japan). The total cross-sectional skeletal muscle area (SMA) at the level of the third lumbar vertebra was calculated in the study population using Hounsfield unit thresholds of −29 to +150 for skeletal muscle \[[@CR12]\]. The details of the measuring method are as described previously \[[@CR13], [@CR14]\]. In this study, the SMA (cm^2^) was divided by BSA (m^2^) to obtain the SMA/BSA index (SBI; cm^2^/m^2^), which is our original method of defining sarcopenia \[[@CR14]\]. In the present study, patients with values less than the gender-specific lowest quartile of SBI were considered to have radiographic sarcopenia.

Postoperative outcomes {#Sec7}
----------------------

For each patient, data regarding the following parameters were collected: postoperative mortality, morbidity including infectious complications, and postoperative length of hospital stay. Postoperative mortality included all in-hospital deaths before discharge. To analyze morbidity severity, each postoperative event was assessed and graded according to the Clavien--Dindo classification \[[@CR15]\]. The major postoperative complications were defined as Clavien grade ≥ 3. POPF and delayed gastric emptying (DGE) were defined according to the International Study Group of Pancreatic Surgery guidelines \[[@CR16], [@CR17]\].

Infectious complications {#Sec8}
------------------------

In the present study, we defined infectious complications as all postoperative infectious diseases including wound infections, infected abdominal fluid, intra-abdominal abscess, bacteremia, catheter-related infections, pneumonia, cholangitis, enteritis, and urinary tract infections. The definition of these infectious complications conformed to those of the American College of Surgeons National Surgical Quality Improvement Program criteria (NSQIP) \[[@CR18]\]. Infected abdominal fluid was defined as drainage fluid with a positive culture from surgically replaced drains. Intra-abdominal abscess was defined as intra-abdominal fluid collection with positive cultures identified by ultrasonography or CT with clinical signs. A positive culture was not necessarily required in cases in which the NSQIP criteria were met and clinical signs were consistent with infectious complications.

Risk factors for postoperative infections {#Sec9}
-----------------------------------------

Univariate and multivariate analyses were performed to identify the predictors closely related to infectious complications after PD among preoperative and intraoperative factors.

Simple scoring system using perioperative risk factors {#Sec10}
------------------------------------------------------

A simple scoring system was performed according to the results of multivariate analysis to investigate risk factors for postoperative infections. Patients were divided into three groups according to these risk factors, and the short-term outcomes of each group were then examined.

Statistical analysis {#Sec11}
--------------------

JMP version 11 software (SAS Institute, Cary, NC) was used for all statistical analyses. Data were presented as means, medians, and standard deviations for continuous variables. Categorical data were presented as proportions. Differences between groups were assessed using the Mann-Whitney U-test for continuous variables, and Fisher's exact test or chi-square test for categorical variables. To investigate the impact of prognostic factors associated with postoperative infections, we used a logistic regression model for univariate and multivariate analyses; odds ratios and 95% confidence intervals were calculated. A *P*--value \<0.05 was considered statistically significant.

Results {#Sec12}
=======

Study population {#Sec13}
----------------

Of the 241 patients who underwent PD, 22 were excluded because of the following reasons: unavailable preoperative CT images, 16; emergency surgery, 6. The demographic characteristics of the 219 patients (143 men \[65.3%\]; mean age, 65.9 years) are shown in Table [1](#Tab1){ref-type="table"}. Pancreatic adenocarcinoma was the most common disease, occurring in 86 patients (39.3%). Preoperative biliary drainage was performed in 101 patients (46.1%). The mean operative time was 448 min (230--733 min) and the mean blood loss was 563 mL (10--3130 mL).Table 1Demographic and clinicopathological factors in patients with and without sarcopenia who underwent pancreaticoduodenectomyAll patients\
(*n* = 219)Non-sarcopenia\
(*n* = 164)Sarcopenia\
(*n* = 55)*P*-valueDemographic variables Sex (men)143 (65.3)107 (65.2)36 (65.5)0.98 Age (years)65.9 (11.7)65.1 (12.4)68.2 (9.2)0.18 BMI (kg/m^2^)21.9 (3.3)22.0 (3.4)21.7 (3.0)0.67ASA physical status 1--2/3203/16154/1049/60.25Laboratory value Albumin (g/dL)4.0 (0.5)4.1 (0.4)3.9 (0.6)0.006 Total lymphocyte (/mm^3^)1642 (554)1665 (561)1572 (521)0.30Child--Pugh score A/B205/14155/950/50.36Comorbidities Hypertension89 (40.6)68 (41.5)21 (38.2)0.67 Diabetes64 (29.2)43 (26.2)21 (38.2)0.10Etiology of the disease Pancreatic adenocarcinoma86 (39.3)61 (37.2)25 (45.5)0.31 Bile duct carcinoma27 (12.3)20 (12.2)7 (12.7) Ampullary adenocarcinoma28 (12.8)18 (11.0)10 (18.2) Duodenal adenocarcinoma10 (4.6)9 (5.5)1 (1.8) IPMN32 (14.6)26 (15.9)6 (10.9) Others36 (16.4)30 (18.3)6 (10.9) Preoperative biliary drainage101 (46.1)68 (41.5)33 (60.0)0.02Intraoperative factor Operative time (min)448 (93)445 (93)454 (94)0.64 Blood loss (mL)563 (486)543 (443)624 (596)0.96 Vascular reconstruction50 (22.8)37 (22.6)13 (23.6)0.87 Soft pancreatic texture133 (60.7)101 (61.6)32 (58.2)0.66 Normal pancreatic duct (\< 3 mm)87 (39.7)69 (42.1)18 (32.7)0.22Data are presented as numbers (percentages) or means (± standard deviation).*BMI* body mass index, *ASA* American Society of Anesthesiologists, *IPMN* intraductal papillary mucinous neoplasm

Measurement of body composition {#Sec14}
-------------------------------

The mean SBI values were 74.7 ± 9.9 cm^2^/m^2^ for men and 58.3 ± 8.3 cm^2^/m^2^ for women. The mean SBI was significantly lower for women than for men (*P* \< 0.001). The cut-off values for the lowest quartiles of SBI were 68.5 cm^2^/m^2^ for men and 52.5 cm^2^/m^2^ for women. Accordingly, 52 patients were categorized as having sarcopenia.

Postoperative outcomes {#Sec15}
----------------------

The mortality and major complication rates for all 219 patients were 1.4% and 16.4%, respectively (Table [2](#Tab2){ref-type="table"}). All three cases of mortality were caused by severe infectious complications. Of 219 patients, 103 (47.0%) had at least one postoperative infection. The most common infectious complications were infected abdominal fluid, 65; wound infections, 35; and intra-abdominal abscess, 12. The incidence rates of clinically relevant POPF (grade B or C) and DGE were 32.9% and 21.9%, respectively. The median length of hospital stay was 30 d (interquartile range, 24--40 d).Table 2Postoperative outcomes in patients with and without sarcopenia who underwent pancreaticoduodenectomyAll patients (*n* = 219)Non-sarcopenia\
(*n* = 164)Sarcopenia\
(*n* = 55)*P*-valueMortality3 (1.4)0 (0)3 (5.5)0.004Major complication36 (16.4)24 (14.6)12 (21.8)0.21Any infectious complication103 (47.0)66 (40.2)37 (67.3)\<0.001Wound infection35 (16.0)26 (15.9)9 (16.4)0.93Intra-abdominal abscess12 (5.5)6 (3.7)6 (10.9)0.04infected abdominal fluid65 (29.7)41 (25.0)24 (43.6)0.009Bacteremia7 (3.2)2 (1.2)5 (9.1)0.004Catheter-related infection,9 (4.1)7 (4.3)2 (3.6)0.84Pneumonia4 (1.8)1 (0.6)3 (5.5)0.02Cholangitis8 (3.7)4 (2.4)4 (7.3)0.10Enteritis5 (2.3)5 (3.1)0 (0)0.19Urinary tract infection2 (0.9)1 (0.6)1 (1.8)0.42Pancreatic fistula (Grade B + C)72 (32.9)52 (31.7)20 (36.4)0.52Delayed gastric emptying48 (21.9)36 (22.0)12 (21.8)0.98Length of stay, median (range)30 (24--40)30 (24--38)30 (25--41)0.25Data are presented as numbers (percentages), unless otherwise indicated

The impact of sarcopenia {#Sec16}
------------------------

The clinical demographic characteristics of patients with and without sarcopenia are shown in Table [1](#Tab1){ref-type="table"}. Patients in the sarcopenia group had significantly lower albumin levels and a higher rate of preoperative biliary drainage, but other factors, including intraoperative factors, were not significantly different. Postoperative outcomes associated with the presence or absence of sarcopenia are presented in Table [2](#Tab2){ref-type="table"}. The mortality rate was significantly higher in the sarcopenia group (5.5% vs. 0%, *P* = 0.004). Although the incidences of major complications, POPF, and DGE were not significantly different between the groups, the sarcopenia group had a significantly higher infectious complication rate (67.3% vs. 40.2%, *P* \< 0.001). The length of postoperative hospital stay did not significantly differ between the groups.

Comparison between patients with and without postoperative infections {#Sec17}
---------------------------------------------------------------------

Patient characteristics are shown in Table [3](#Tab3){ref-type="table"}. There were no differences between patients with and without infections with respect to sex, age, BMI, ASA physical status, laboratory values, liver function, comorbidities, etiology of disease, blood loss, vascular reconstruction, and pancreatic duct diameter. Sarcopenia, preoperative biliary drainage, operative time, and soft pancreatic texture were more common (or longer, in the case of operative time) in patients with infections.Table 3Univariate and multivariate analyses of perioperative predictors associated with postoperative infections in patients who underwent pancreaticoduodenectomyVariableUnivariate analysisMultivariate analysisNon-infection (*n* = 116)Infection (*n* = 103)OR95% CI*P*-valueOR95% CI*P*-valueSarcopenia18 (15.5)37 (35.9)3.051.62--5.91\<0.0013.431.71--7.14\<0.001Male77 (66.4)66 (64.1)0.900.52--1.580.72Age (≥ 70 years)45(38.8)47 (45.6)1.320.77--2.270.31BMI (≥ 25 kg/m^2^)13 (11.2)21 (20.4)2.030.97--4.390.062.010.87--4.800.10ASA (≥ grade 3)6 (5.2)10 (9.7)1.970.70--5.980.20Albumin (\< 3.6 g/dL)14 (12.4)19 (19.4)1.700.81--3.660.16Child--Pugh score (grade B)4 (3.4)10 (9.7)3.010.97--11.30.061.740.48--7.400.41Diabetes32 (27.6)32 (31.1)1.180.66--2.120.57Malignant disease77 (66.4)74 (71.8)1.290.73--2.310.38Preoperative biliary drainage42 (36.2)59 (57.3)2.361.38--4.090.0022.201.17--4.200.014Operative time (\> 425 min)60 (51.7)69 (67.0)1.891.10--3.300.021.570.83--2.990.17Blood loss (\> 550 mL)39 (33.6)46 (44.7)1.590.92--2.760.091.921.00--3.730.048Vascular reconstruction28 (24.1)23 (22.3)0.950.50--1.780.87Soft pancreatic texture59 (50.9)74 (71.8)2.471.41--4.370.0013.711.96--7.29\<0.001Normal pancreatic duct (\< 3 mm)42 (36.2)45 (43.7)1.370.79--2.360.26Data are presented as numbers (percentages).*OR* odds ratio, *CI* confidence interval, *BMI* body mass index, *ASA* American Society of Anaesthesiologists

Risk factors for postoperative infections {#Sec18}
-----------------------------------------

Table [3](#Tab3){ref-type="table"} shows the results of univariate and multivariate analyses used to identify the predictors closely related to infectious complications after PD. In univariate analysis, four variables (sarcopenia, preoperative biliary drainage, operative time, and soft pancreatic texture) were found to be significant risk factors. Multivariate analysis showed that sarcopenia (odds ratio = 3.43; *P* \< 0.001), preoperative biliary drainage (odds ratio = 2.20; *P* = 0.014), blood loss (odds ratio = 1.92; *P* = 0.048), and soft pancreatic texture (odds ratio = 3.71; *P* \< 0.001) were significant risk factors for infectious complications after PD.

Simple scoring system using perioperative risk factors {#Sec19}
------------------------------------------------------

According to the number of significant risk (R) factors (sarcopenia, preoperative biliary drainage, blood loss, and soft pancreatic texture) in multivariate analysis, patients were divided into three groups: R0/1 group (*n* = 91), R2 group (*n* = 89), and R3/4 group (*n* = 39).

Table [4](#Tab4){ref-type="table"} shows the short-term outcomes after PD determined using the risk-scoring system. The incidence rates of mortality and major complications were not different between the groups. However, the infectious complication rates after PD were 28.6% for the R0/1 group, 49.4% for the R2 group, and 84.6% for the R3/4 group (*P* \< 0.001). In a logistic regression model, all differences between the R0/1 group and other groups were significant.Table 4Short-term outcomes after pancreaticoduodenectomy based on the results of the risk scoring systemNo. of risk factorsMortality*P*-valueMajor complication*P*-valueInfectious complication*P*-valueOR95% CI*P*-valueR0/1 group (*n* = 91)0 (0)0.2011 (12.1)0.1726 (28.6)\<0.001\-\--R2 group (*n* = 89)2 (2.2)15 (16.9)44 (49.4)2.441.33--4.570.004R3/4 group (*n* = 39)1 (2.6)10 (25.6)33 (84.6)13.85.47--40.0\<0.001Data are presented as numbers (percentages).*OR* odds ratio, *CI* confidence interval

Discussion {#Sec20}
==========

This retrospective study demonstrated that sarcopenia is an independent prognostic factor of infectious complications after PD. To the best of our knowledge, this is the first study to identify the prognostic significance of sarcopenia on postoperative infections following PD. Concerning surgical procedures, the standard surgical procedure has changed to subtotal stomach-preserving PD from 2007 at our institution. In addition, the reconstruction of gastrojejunostomy has changed to an antecolic route from 2007 \[[@CR11]\]. However, major changes in surgical procedures have not been introduced after 2007, so the results of this study should be valid.

In the entire cohort, the mortality, major complication, and infectious complication rates after PD were 1.4%, 16.4%, and 47.0%, respectively. The results obtained from our institution were better than those reported in previous papers \[[@CR1], [@CR2], [@CR19]\]. However, the median length of stay was 30 d in the present study, which was much longer than the mean value reported from studies performed in Western countries.

Further improvements to surgical procedures and perioperative management are needed in order to improve postoperative outcomes after PD.

Sarcopenia is a syndrome defined by progressive and generalized loss of skeletal muscle mass and strength that occurs with aging or secondary to diseases \[[@CR20], [@CR21]\]. In the present study, we used preoperative CT to evaluate sarcopenia. CT is considered to be an objective and precise method for assessing sarcopenia \[[@CR22]--[@CR24]\]. Regarding the definition of sarcopenia, we used SBI to evaluate skeletal muscle mass. We considered that SBI would more precisely evaluate skeletal muscle mass in patients with different physiques, and would be a superior index for evaluating skeletal muscle mass \[[@CR14]\]. In the present study, demographic characteristics, including age and body parameters, were not significantly different between the two groups.

The effect of sarcopenia on postoperative complications, especially POPF, has been reported previously \[[@CR5]--[@CR8]\]. In the present study, the incidence rates of major complications and POPF were not significantly different between the two groups. This finding differs from the results of previous studies. However, the sarcopenia group had a significantly higher incidence of in-hospital mortality and infectious complications. All cases of mortality were also the result of severe infectious complications. Concerning infectious complications, the incidence rates of intra-abdominal abscess and infected abdominal fluid were significantly higher in the sarcopenia group. Sarcopenia might negatively affect the healing process at the pancreatic anastomosis \[[@CR6]\].

Our multivariate analysis revealed that sarcopenia, preoperative biliary drainage, blood loss, and soft pancreatic texture were perioperative risk factors related to postoperative infections after PD. Preoperative biliary drainage has been reported to be a risk factor for postoperative infections following PD. \[[@CR25]\] Operative factors and pancreatic factors such as blood loss and soft pancreatic texture have been reported to be associated with POPF after PD, which may also be related to postoperative infections \[[@CR6]\]. However, this represents a new finding demonstrating the association between sarcopenia and infections complications after PD.

In this study, we established a simple and comprehensive scoring system that predicted postoperative infections after PD. Thirty-nine patients (17.8%) had three or four risk factors (the R3/4 group), and these patients had 84.6% of all postoperative infectious complications. Assessing and managing these risk factors may improve postoperative outcomes, especially in high-risk patients. Nutritional intervention combined with physical exercise appear to be effective for the management of sarcopenia \[[@CR26], [@CR27]\]. Furthermore, perioperative antibiotic strategies to prevent bile contamination could prevent infectious complications after PD. \[[@CR28]\] Finally, the development of specialized surgical procedures and techniques might contribute to reducing the rate of infectious complications.

Despite the important findings reported in this study, several limitations should be discussed. First, this was a small, single-center, retrospective study. Because of this, there may be some selection bias with respect to the patients who underwent PD. Second, we did not evaluate functional muscle status in terms of grip strength, walking speed, or exhaustion because of the retrospective nature of the study. The evaluation of both muscle mass and muscle function has been recommended in the diagnosis of sarcopenia \[[@CR21]\], and future studies will be required to assess not only muscle mass but also function in sarcopenia. Third, we used the SBI for evaluating sarcopenia, which would be a useful modality for assessing sarcopenia. However, further studies are needed to assess the efficiency of SBI to diagnosis sarcopenia. Fourth, it remains unclear what nutritional interventions and physical exercise regimens would be valid for patients undergoing PD, because few studies have dealt with the effects of such interventions on sarcopenic patients with PD. Future studies are needed to examine the effects of perioperative interventions focusing on sarcopenia. Finally, there is insufficient evidence in the pathophysiology concerning the interaction between sarcopenia and infections. The depletion of skeletal muscle as a secretory organ of cytokines and peptides, and increasing adipose tissue as a key component of the immune system lead to the synthesis and secretion of several proinflammatory adipocytokines \[[@CR29]\]. Thereby, decreased interleukin-15 and increased adipokines levels might be associated with the interaction between sarcopenia and immune depression \[[@CR30]\]. Accordingly, We hypothesize that sarcopenia reflects the patients' frailty, including impaired immune function, which ultimately leads to infections \[[@CR14]\]. However, further research should investigate the molecular mechanism of sarcopenia's effect on outcomes.

Conclusions {#Sec21}
===========

In conclusion, the results of the present study indicate that sarcopenia is an objective and independent preoperative predictor of infectious complications after PD. Furthermore, assessing sarcopenia is easy and practicable. Accordingly, we propose that clinical assessment combined with sarcopenia may help clinicians to understand the risk of postoperative outcomes and determine perioperative management strategies.
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